Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (NY: BLCO ) 20.51 +0.23 (+1.13%) Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about BLCO < Previous 1 2 3 Next > Bausch + Lomb Announces Third-Quarter 2024 Results October 30, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens October 14, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30 October 09, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Launches Opal™ Digital Marketplace in the United States October 01, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value September 25, 2024 The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden. Via MarketBeat Bausch + Lomb Announces Second-Quarter 2024 Results July 31, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31 July 11, 2024 From Bausch + Lomb Corporation Via Business Wire Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief July 08, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress June 17, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States June 10, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States June 03, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results May 29, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting® May 28, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens May 28, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces First-Quarter 2024 Results May 01, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting April 29, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes April 25, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs April 18, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1 April 15, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting March 27, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors February 28, 2024 From Bausch + Lomb Corporation Via Business Wire Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO February 21, 2024 From Emergent BioSolutions Via GlobeNewswire Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance February 21, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21 February 05, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery January 08, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs November 15, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance November 01, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting October 26, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1 October 16, 2023 From Bausch + Lomb Corporation Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
